{
  "nct_id": "NCT04428671",
  "official_title": "Pilot Study of Neoadjuvant/Adjuvant Cemiplimab for High Risk Cutaneous Squamous Cell Carcinoma",
  "brief_title": "Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer",
  "cancer_type_display": "A study of cemiplimab given before and after surgery for patients with high-risk, resectable cutaneous squamous cell carcinoma (cSCC), including metastatic or recurrent disease.",
  "cancer_tags": [
    "Metastatic Skin Squamous Cell Carcinoma",
    "Recurrent Skin Squamous Cell Carcinoma"
  ],
  "link_to_trial": "https://clinicaltrials.gov/study/NCT04428671",
  "phase": "Phase 1",
  "recruitment_status": "RECRUITING",
  "last_update_date": "2025-08-14",
  "enrollment": 20,
  "min_age": 18,
  "max_age": null,
  "sex": "ALL",
  "is_metastatic_allowed": true,
  "performance_status_scale": "ECOG",
  "performance_status_values": [
    0,
    1
  ],
  "min_prior_lines": 0,
  "max_prior_lines": 0,
  "prior_treatments_required": null,
  "prior_treatments_excluded": [
    "Prior systemic immunotherapy",
    "Prior anti-PD1 therapy",
    "Treatment with chronic immunosuppressants",
    "Prior organ allograft or allogeneic bone marrow transplantation"
  ],
  "principal_investigator": "Michael Lowe, MD",
  "site_name": "Emory University/Winship Cancer Institute",
  "contact_email": "allyson.anderson@emory.edu",
  "contact_phone": "404-251-2854",
  "locations": [
    {
      "facility": "Emory University/Winship Cancer Institute",
      "status": "RECRUITING",
      "city": "Atlanta",
      "state": "Georgia",
      "zip": "30322",
      "country": "United States",
      "contacts": [
        {
          "name": "Allyson R. Anderson",
          "role": "CONTACT",
          "phone": "404-251-2854",
          "email": "allyson.anderson@emory.edu"
        },
        {
          "name": "Michael Lowe, MD",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "geoPoint": {
        "lat": 33.749,
        "lon": -84.38798
      }
    }
  ],
  "key_inclusion_summary": [
    "Diagnosis of high-risk cutaneous squamous cell carcinoma (cSCC) based on specific criteria (e.g., nodal disease with ECE, in-transit metastases, T4 lesion, perineural invasion, or specific recurrent features).",
    "Cancer confirmed to be surgically resectable.",
    "No prior systemic immunotherapy or anti-PD1 therapy.",
    "ECOG performance status of 0 or 1.",
    "Adequate organ and marrow function."
  ],
  "key_exclusion_summary": [
    "Not a surgical candidate due to medical co-morbidities or extent of disease.",
    "Treatment with chronic immunosuppressants or prior organ/bone marrow transplant.",
    "Active or history of immune-mediated conditions like pneumonitis, colitis, hepatitis, etc.",
    "Requires systemic treatment with corticosteroids (> 10 mg daily prednisone equivalent).",
    "Women who are pregnant or lactating."
  ]
}